Cargando…

A glance at the application of CRISPR/Cas9 gene-editing technology in cardiovascular diseases

Cardiovascular diseases (CVDs) remain major causes of global mortality in the world. Genetic approaches have succeeded in discovery of the molecular basis of an increasing number of cardiac diseases. Genome editing strategies are one of the most effective methods for assisting therapeutic approaches...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roshanravan, Neda, Tutunchi, Helda, Najafipour, Farzad, Dastouri, Mohammadreza, Ghaffari, Samad, Jebeli, Alireza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tabriz University of Medical Sciences 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339732/ https://www.ncbi.nlm.nih.gov/pubmed/35935390 http://dx.doi.org/10.34172/jcvtr.2022.14

Ejemplares similares

Oleoylethanolamide, A Bioactive Lipid Amide, as A Promising Treatment Strategy for Coronavirus/COVID-19
por: Ghaffari, Samad, et al.
Publicado: (2020)

Role of Butyrate, a Gut Microbiota Derived Metabolite, in Cardiovascular Diseases: A comprehensive narrative review
por: Amiri, Parichehr, et al.
Publicado: (2022)

What hematological and endocrinal indicators are important in COVID-19 infection?
por: Ostadrahimi, Alireza, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease across endocrinopathies: Interaction with sex hormones
por: Arefhosseini, Sara, et al.
Publicado: (2022)

Human cardiac organoids: A recent revolution in disease modeling and regenerative medicine
por: Roshanravan, Neda, et al.
Publicado: (2023)

Applications of CRISPR-Cas9 as an Advanced Genome Editing System in Life Sciences
por: Tavakoli, Kamand, et al.
Publicado: (2021)

Possible therapeutic effects of boron citrate and oleoylethanolamide supplementation in patients with COVID-19: A pilot randomized, double-blind, clinical trial
por: Akbari, Neda, et al.
Publicado: (2022)

Bioethical issues in genome editing by CRISPR-Cas9 technology
por: AYANOĞLU, Fatma Betül, et al.
Publicado: (2020)

Effects of levothyroxine replacement therapy on insulin resistance in patients with untreated primary hypothyroidism
por: Ostadrahimi, Alireza, et al.
Publicado: (2023)

Myo-inositol supplementation improves cardiometabolic factors, anthropometric measures, and liver function in obese patients with non-alcoholic fatty liver disease
por: Arefhosseini, Sara, et al.
Publicado: (2023)

Redefining mouse transgenesis with CRISPR/Cas9 genome editing technology
por: Burgio, Gaetan
Publicado: (2018)

Edition of TFAM gene by CRISPR/Cas9 technology in bovine model
por: de Oliveira, Vanessa Cristina, et al.
Publicado: (2019)

Efficient Genome Editing Using CRISPR/Cas9 Technology in Chicory
por: Bernard, Guillaume, et al.
Publicado: (2019)

Applications of CRISPR-Cas9 Technology to Genome Editing in Glioblastoma Multiforme
por: Al-Sammarraie, Nadia, et al.
Publicado: (2021)

Effects of oleoylethanolamide supplementation on inflammatory biomarkers, oxidative stress and antioxidant parameters of obese patients with NAFLD on a calorie-restricted diet: A randomized controlled trial
por: Tutunchi, Helda, et al.
Publicado: (2023)

Iran’s Bushehr Earthquake at a Glance
por: Khanli, Hadi Mohammad, et al.
Publicado: (2013)

CRISPR/Cas9 or prime editing? – It depends on…
por: Schenke, Dirk
Publicado: (2020)

Correction to: Redefining mouse transgenesis with CRISPR/Cas9 genome editing technology
por: Burgio, Gaetan
Publicado: (2018)

CRISPR/Cas9 genome editing technology in filamentous fungi: progress and perspective
por: Song, Runjie, et al.
Publicado: (2019)

Optimized protocol for gene editing in adipocytes using CRISPR-Cas9 technology
por: Qiu, Yan, et al.
Publicado: (2021)

Review of applications of CRISPR-Cas9 gene-editing technology in cancer research
por: Zhao, Ziyi, et al.
Publicado: (2021)

Application progress of CRISPR/Cas9 genome-editing technology in edible fungi
por: Zhang, Yan, et al.
Publicado: (2023)

CRISPR-Cas9 DNA Base-Editing and Prime-Editing
por: Kantor, Ariel, et al.
Publicado: (2020)

Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
por: Zhang, Song, et al.
Publicado: (2021)

Targeted genome and epigenome editing using engineered TALE and CRISPR/Cas9 technologies
por: Gersbach, Charles A
Publicado: (2014)

CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease
por: Rahman, Mujeeb ur, et al.
Publicado: (2022)

CRISPR/Cas9 Genome-Editing Technology and Potential Clinical Application in Gastric Cancer
por: Almeida, Renata Sanches, et al.
Publicado: (2022)

Inducible in vivo genome editing with CRISPR/Cas9
por: Dow, Lukas E, et al.
Publicado: (2015)

Efficient Mitochondrial Genome Editing by CRISPR/Cas9
por: Jo, Areum, et al.
Publicado: (2015)

CRISPR/Cas9: Transcending the Reality of Genome Editing
por: Chira, Sergiu, et al.
Publicado: (2017)

Genome Editing in Cotton with the CRISPR/Cas9 System
por: Gao, Wei, et al.
Publicado: (2017)

CRISPR/Cas9 Editing for Gaucher Disease Modelling
por: Pavan, Eleonora, et al.
Publicado: (2020)

Spatiotemporal control of CRISPR/Cas9 gene editing
por: Zhuo, Chenya, et al.
Publicado: (2021)

Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
por: Duan, Li, et al.
Publicado: (2021)

CRISPR–Cas9 Based Bacteriophage Genome Editing
por: Zhang, Xueli, et al.
Publicado: (2022)

CRISPR/Cas9 genome editing for neurodegenerative diseases
por: Nouri Nojadeh, Jafar, et al.
Publicado: (2023)

CRISPR-Cas9 gene editing and human diseases
por: Jinka, Chaitra, et al.
Publicado: (2022)

CRISPR/Cas9 Essential Gene Editing in Drosophila
por: Osadchiy, I. S., et al.
Publicado: (2023)

Angiotensin converting enzyme-2 as therapeutic target in COVID-19
por: Roshanravan, Neda, et al.
Publicado: (2020)

Targeting Cytokine Storm to Manage Patients with COVID-19: A Mini-Review
por: Roshanravan, Neda, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6vtkvrj2jphfsj2i395vju2pnt